Moderna’s stock jumps after biotech raises sales outlook
The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026.
The report was published on 06 de novembro de 2026 às 09:10 by MarketWatch and is part of the World news coverage.
What other outlets are saying
- CNBC: Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
- WSJ: Moderna Swings to Profit, Lifts Outlook as Covid-19 Vaccine Demand Stabilizes
Quick answers
Who reported this story?
It was first reported by MarketWatch on 06 de novembro de 2026 às 09:10.
What is the category?
It is filed under World news on Rio Warzone News.
